Celanese Q4 adjusted EPS falls to $0.67 from $1.33; full-year loss narrows
Celanese reported fourth-quarter and full-year 2025 results on February 17, 2026. Full-year net sales fell 7% to $9.5 billion, and adjusted EPS was $3.98 versus $8.18 in 2024, while the full-year U.S. GAAP diluted loss per share from continuing operations narrowed to $10.44 from $14.04. The company also guided first-quarter 2026 adjusted EPS to $0.70 to $0.85 and targets 2026 free cash flow of $650 million to $750 million.
Key points
- Q4 2025 net sales were $2.2 billion, down 9% from the prior quarter and slightly below $2.358 billion in Q4 2024; Q4 adjusted EPS was $0.67 versus $1.33 a year earlier.
- Full-year 2025 free cash flow was $773 million, up from $498 million in 2024, and operating cash flow was $1.1 billion.
- Full-year 2025 results include Certain Items totaling $1.6 billion, primarily a goodwill and trade name impairment, which drove the U.S. GAAP loss.
- First-quarter 2026 adjusted EPS guidance is $0.70 to $0.85, and the company targets 2026 free cash flow of $650 million to $750 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 17, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.